Launches in European Markets

We are delighted to announce that Sialanar, licenced throughout Europe as a Paediatric Use Marketing Authorisation (PUMA), has been granted full reimbursement from the Swedish Pricing and Reimbursement authority and is now available in Sweden, Denmark and Norway via our partner Anthrop Pharmaceuticals AB  ( 

Sialanar is also available in Germany and Ireland. Future launches in other European countries will be announced in due course.